You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser
Site Exit Disclaimer
You are now leaving the website of EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.
If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website.
Share Disclaimer
By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Despite continued advances in treatment, the global impact of cancer takes a heavy toll, with an estimated 19.3 million diagnoses and almost 10 million cancer related deaths in 2020 alone.1
Our curiosity drives our goal to unleash approaches in cancer research, driving us to help transform care for challenging cancers.
We apply our scientific curiosity to tackling challenging tumor types in key areas —skin, renal, urothelial, and lung cancers — where there are unmet needs and where we believe we can help drive transformation of patient care.
Addressing the Challenge
We complement our scientific expertise through external collaborations with thought leaders in the cancer community — from industry, to academic institutions, to leading cancer centers and insights from patients and caregivers.
Since 2016, we have collaborated with more than 19 leading oncology patient organizations in the US.
These collaborations encompass activities such as disease awareness campaigns, production of educational materials and events organized by the patient community, digital health projects, data collection projects e.g. surveys, and insights collected from patients.
1 Sung, H et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA CANCER J CLIN. 2021;71:209–249.
